Publicaciones en colaboración con investigadores/as de Massachusetts General Hospital (4)

2023

  1. Safety and clinical activity of atezolizumab plus erlotinib in patients with non-small-cell lung cancer

    ESMO Open, Vol. 8, Núm. 2

2020

  1. A phase 1b study of the MET inhibitor capmatinib combined with cetuximab in patients with MET-positive colorectal cancer who had progressed following anti-EGFR monoclonal antibody treatment

    Investigational New Drugs, Vol. 38, Núm. 6, pp. 1774-1783

  2. Antitumor activity of ipatasertib combined with chemotherapy: results from a phase Ib study in solid tumors

    Annals of Oncology, Vol. 31, Núm. 5, pp. 626-633

2019

  1. Definition of the rectum: An International, expert-based Delphi consensus

    Annals of Surgery, Vol. 270, Núm. 6, pp. 955-959